Brooke Ruane
Acute Care · Philadelphia, PANPI 1154895241
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,808 of the $2,833 with a category attached, or 63.8%. GSK accounts for 61.2% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $1,639, 6.7 times the $243 reported in 2021. Among acute care clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 71 payments — averaging $39.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$2K
- Pulmonx Corporation$247
- Sanofi$138
- AstraZeneca$126
- Insmed, Inc.$126
- Boehringer Ingelheim$116
- plus $347 from 8 others
What the payments were for
- Consulting fees$90032%
- Travel & lodging$462%
- Food & beverage$1,80864%
- Education$803%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 31 | $1,734 |
| Pulmonx Corporation | 3 | $247 |
| Sanofi | 5 | $138 |
| AstraZeneca | 8 | $126 |
| Insmed, Inc. | 4 | $126 |
| Boehringer Ingelheim | 6 | $116 |
| Regeneron Healthcare Solutions, Inc. | 4 | $99 |
| Bayer | 3 | $63 |
| Baxter Healthcare | 1 | $43 |
| Electromed, Inc. | 2 | $30 |
| Actelion Pharmaceuticals US, Inc. | 1 | $29 |
| Verona Pharma, Inc. | 1 | $28 |
| Averitas Pharma Inc. | 1 | $28 |
| Sanofi Pasteur Inc. | 1 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,833 in reported general payments places this provider in the 90th percentile of 872 acute care providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 60 | $42,207 |
| Varenicline Tartrate | 59 | $23,404 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 20 | $10,050 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 22 | $3,870 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 123 | $3,518 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 19 | $3,004 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $2,530 |
| Bupropion Hcl SrBupropion Hcl | 15 | $446 |
| Fluticasone Propionate | 17 | $187 |
| Montelukast Sodium | 25 | $183 |
| Prednisone | 11 | $20 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta | $1,734 | $52,25780 claims |
| AstraZenecaSymbicort | $126 | $2,53012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 872 acute care providers in Pennsylvania.
Other acute care in Philadelphia
- Kathryn GreenPhiladelphia$92K
- Caroline PratzPhiladelphia$77K
- Rebecca MarcantuonoPhiladelphia$17K
- Stephanie TothPhiladelphia$17K
- David JonesPhiladelphia$11K
- Colleen KollerPhiladelphia$11K
- Maura LevandowskiPhiladelphia$9K
- Christopher SipalaPhiladelphia$9K
- Amaryah YaegerPhiladelphia$7K
- Shane RudolphPhiladelphia$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.